WUSTL

rss Business & Law

This week’s announcement that HBO will begin offering new video streaming service without a cable subscription is likely to have significant impact on the television industry. And the ripple effect could happen fast, according to Raphael Thomadsen, PhD, associate professor of marketing in Olin Business School at Washington University in St. Louis.MORE
The business of sports, said Joseph S. Lacob (left), co-executive chairman and CEO of the NBA’s Golden State Warriors, isn’t just fun and games. Future successful sports industry leaders must be innovative thinkers with a solid foundational business background, like the new minor in the business of sports at Olin Business School, a program he is helping launch with a $1 million gift.MORE

Pharmaceutical companies have largely abandoned the business of discovering and developing antibiotics and our stock of these "miracle drugs" is beginning to shrink. Michael Kinch and his colleagues at Washington University in St. Louis are working to create new models for drug discovery that could replace the failed private enterprise model.


MORE

Several “blockbuster” cases — including freedom of speech, religious freedoms in prison, pregnancy discrimination and a possible decision on gay marriage — are on the docket for the Supreme Court, which begins its new session this month. But don’t expect any decisions until next June. New research led by the School of Law finds big cases are disproportionately decided just before the court’s summer recess.

MORE

The U.S. Treasury Department has taken action to curb corporate tax inversions, making it more difficult to for U.S. companies to merge with international firms and move abroad to reduce their taxes. This move attempts to combat specific abuses within a flawed framework, according to an international tax law expert at Washington University in St. Louis School of Law.

MORE
Over the past several decades, Michael Kinch of Washington University in St. Louis says, the pharmaceutical industry has managed to dismantle itself. In a provocative series of articles and interviews, Kinch, the director of the Center for Research Innovation in Businessat the university, has been describing the history of this dismantling and its implications for the future of medicine.MORE
Corporate tax inversions — reincorporating overseas by transferring assets to a smaller company in a country where the corporate tax rate is lower — have become quite popular with American companies lately, forcing the Treasury Department to issue new rules aimed at curbing them. The benefit of changing a firm’s home base to lower its effective tax rate is obvious, the study, led by Radhakrishnan Gopalan of Olin Business School finds. However, the costs of inversion are not well understood.MORE
media contacts
Neil Schoenherr
Senior News Director
(314) 935-5235
nschoenherr@wustl.edu